Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Synopsys Inc (NQ: SNPS )

564.33 +6.39 (+1.15%)
Streaming Delayed Price Updated: 12:57 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Synopsys Inc

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Why Jim Cramer Prefers This Home Builder Stock To Skyline Champion
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Alibaba Group Holding Limited (NYSE: BABA) can go higher, but he is not recommending any Chinese shares. 
Via Benzinga
Here's How Much $100 Invested In Synopsys 10 Years Ago Would Be Worth Today
Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 15.1% on an annualized basis producing an average annual return of 25.9%. Currently, Synopsys has a market capitalization of... 
Via Benzinga
Analyst Downgrades Texas Instruments And Skyworks, Upgrades These 2 Semi Stocks
Semiconductor stocks have taken a big hit so far in 2022, and one Wall Street analyst just adjusted his ratings on six semis heading into the second half of the year. The Analyst: Bank of America... 
Via Benzinga
Chip Design Firms Upgraded As Chipmakers Downgraded
A Wall Street firm downgraded several semiconductor stocks as the outlook for chip sales ebbs, but it upgraded two chip design firms. 
Via Investor's Business Daily
IBD Rating Upgrades: Synopsys Shows Improved Relative Price Strength
Synopsys shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
Synopsys Ranks No. 1 Among Software Makers
Synopsys sees its Relative Strength Rating move into the 80-plus level. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2022
Upgrades 
Via Benzinga
Walmart And 3 Other Stocks Insiders Are Selling
US stock futures traded slightly higher this morning on Monday after recording sharp gains in the previous session. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Introducing Trustworthy: An All-In-One Solution For Life's Most Important Documents
The average person has thousands of personal documents to their name. Nearly every critical personal piece of information, from identification to finances to property, features... 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,900 Today
Synopsys (NASDAQ:SNPS) has outperformed the market over the past 5 years by 22.62% on an annualized basis producing an average annual return of 31.23%. Currently, Synopsys has a market capitalization... 
Via Benzinga
Here's How Much You Would Have Made Owning Synopsys Stock In The Last 10 Years
Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 15.2% on an annualized basis producing an average annual return of 27.35%. Currently, Synopsys has a market capitalization... 
Via Benzinga
Best Stocks To Buy Now: Sunday, May 29, 2022
There’s no denying that investing can be risky, especially in today’s volatile market. But if you know what you’re doing, 
Via Best Stocks
Design Software Leader Synopsys' Stock Earns Rating Upgrade
The new 84 RS Rating shows that Synopsys stock has outperformed 84% of all companies in terms of stock price performance. 
Via Investor's Business Daily
Stock Market Rally Under Pressure As Walmart, Target Crash On Inflation Woes: Weekly Review
A confirmed market uptrend is reeling as inflation's pain bites. 
Via Investor's Business Daily
Markets Finish Lower Following Wednesday's Intense Sell-Off
U.S. indices finished Thursday's trading session lower. Worse-than-expected retail earnings and anticipation of further Federal Reserve policy tightening in 2022 have continued to weigh on stocks... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for... 
Via Benzinga
71 Biggest Movers From Yesterday
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation... 
Via Benzinga
Synopsys Stock Gains After Q2 Results Tops Estimates, Raised FY22 Guidance
Synopsys, Inc. (NASDAQ: SNPS) reported secon 
Via Benzinga
Recap: Synopsys Q2 Earnings
Synopsys (NASDAQ:SNPS) reported its Q2 earnings results on Wednesday, May 18, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Synopsys beat estimated earnings by... 
Via Benzinga
Synopsys Easily Tops Quarterly Sales, Earnings Targets
Synopsys, a maker of chip design software, late Wednesday handily beat analyst estimates for its fiscal second quarter. SNPS stock rose. 
Via Investor's Business Daily
Earnings Scheduled For May 18, 2022
Companies Reporting Before The Bell • Sypris Solutions (NASDAQ:SYPR) is projected to report earnings for its first quarter. 
Via Benzinga
Synopsys's Earnings: A Preview
Synopsys (NASDAQ:SNPS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-18. Here's what investors need to know before the announcement. Analysts estimate that Synopsys will... 
Via Benzinga
Sunday Shorts - May 15
Tim Knight reviews the charts of his current option picks. Give a look. 
Via Talk Markets
NASDAQ: SNPS Investor Notice: Investigation over Possible Securities Laws Violations by Synopsys, Inc.
San Diego, CA -- (SBWIRE) -- 04/26/2022 -- An investigation for investors in Synopsys, Inc. (NASDAQ: SNPS) shares over potential securities laws violations by Synopsys, Inc. was announced. 
Via SBWire
Cadence Design Systems Beats First-Quarter Sales, Earnings Targets
Cadence Design Systems, a maker of electronic systems design software, handily beat Wall Street's first-quarter targets. CDNS stock rose. 
Via Investor's Business Daily
SYNOPSYS ALERT: Bragar Eagel & Squire, P.C. is Investigating Synopsys, Inc. on Behalf of Synopsys Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
SYNOPSYS ALERT: Bragar Eagel & Squire, P.C. is Investigating Synopsys, Inc. on Behalf of Synopsys Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Synopsys, Inc. (SNPS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Synopsys, Inc. (SNPS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Synopsys, Inc. (SNPS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.